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Abstract
Background: SHV b-lactamases confer resistance to a broad range of antibiotics by accumulating mutations. The
number of SHV variants is steadily increasing. 117 SHV variants have been assigned in the SHV mutation table
(http://www.lahey.org/Studies/). Besides, information about SHV b-lactamases can be found in the rapidly growing
NCBI protein database. The SHV b-Lactamase Engineering Database (SHVED) has been developed to collect the
SHV b-lactamase sequences from the NCBI protein database and the SHV mutation table. It serves as a tool for the
detection and reconciliation of inconsistencies, and for the identification of new SHV variants and amino acid
substitutions.
Description: The SHVED contains 200 protein entries with distinct sequences and 20 crystal structures. 83 protein
sequences are included in the both the SHV mutation table and the NCBI protein database, while 35 and 82
protein sequences are only in the SHV mutation table and the NCBI protein database, respectively. Of these 82
sequences, 41 originate from microbial sources, and 22 of them are full-length sequences that harbour a mutation
profile which has not been classified yet in the SHV mutation table. 27 protein entries from the NCBI protein
database were found to have an inconsistency in SHV name identification. These inconsistencies were reconciled
using information from the SHV mutation table and stored in the SHVED.
The SHVED is accessible at http://www.LacED.uni-stuttgart.de/classA/SHVED/. It provides sequences, structures, and
a multisequence alignment of SHV b-lactamases with the corrected annotation. Amino acid substitutions at each
position are also provided. The SHVED is updated monthly and supplies all data for download.
Conclusions: The SHV b-Lactamase Engineering Database (SHVED) contains information about SHV variants with
reconciled annotation. It serves as a tool for detection of inconsistencies in the NCBI protein database, helps to
identify new mutations resulting in new SHV variants, and thus supports the investigation of sequence-function
relationships of SHV b-lactamases.
Background
Since the application of penicillin to the clinical practice in
the 1940s, the effectiveness of b-lactam antibiotics have
been reduced drastically [1-3]. One of the main reasons
is the hydrolysis of their b-lactam ring by b-lactamases
(EC 3.5.2.6) resulting in a loss of function. These enzymes,
especially SHV and TEM b-lactamase variants, accumulate
mutations gradually [4,5] to resist b-lactam antibiotics and
rapidly spread over the world [6-8].
SHV b-lactamases belong to class A b-lactamases and
have a serine in the active site [9]. The premature pro-
tein consists of 286 amino acids. The first 21 amino
acids at the N-terminus form the signal sequence and
are removed to yield the mature enzyme [10]. SHV
b-lactamases were first described in the members of the
genus Klebsiella as a narrow-spectrum b-lactamase
against penicillin [6,11]. Their genes are located either
in the bacterial chromosome or on a plasmid [12].
Genes encoding these enzymes have been mutated
rapidly and transferred to other Gram-negative bacteria
in different geographical regions [6]. Currently, 117
SHV variants have been described. A list of assigned
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and Bush [13] which is referred further in this paper as
“SHV mutation table”. Beside the SHV mutation table,
sequence information on SHV b-lactamases can also be
found in the NCBI protein database [14]. One of the
important data sources of the NCBI protein database is
the NCBI nucleotide database which is open for submis-
sion of new sequences without further validation; there-
fore it is growing rapidly, but contains inconsistencies.
In contrast, the SHV mutation table is manually curated
by experts in the b-lactamase field and therefore is
widely accepted as a reliable and consistent information
source. In the SHV mutation table, each SHV variant is
characterized by its name and mutation profile which is
a set of amino acid substitutions at certain positions in
the sequence. Positions are identified according to the
Ambler numbering scheme [15]. To become listed in
the SHV mutation table as a new SHV b-lactamase, it
must have arisen naturally, is fully sequenced, and har-
bors a new mutation profile [13]. Therefore, engineered
proteins are not considered.
The SHV Engineering Database (SHVED) was built up
as a comprehensive inventory by collecting data on SHV
b-lactamases from these two databases to facilitate
detection of inconsistencies in entries derived from
NCBI protein database and to eventually reconcile them,
to detect new SHV b-lactamases with novel mutation
profiles, and to identify new amino acid positions at
which mutations can occur.
Construction and content
Construction
Development and construction of SHVED
Amino acid sequence of SHV-1 originated from Kleb-
siella pneumoniae (GenInfo (GI): 4337048) was used as
a seed sequence for building up the SHVED. A BLAST
search [16] was performed against the NCBI protein
database [14] without filtering of low complexity regions
and with a low E-value threshold (10
-124)t op r e v e n tt h e
occurrence of TEM lactamases and other non-SHV lac-
tamases in the BLAST results. For each hit in the
BLAST result, the GI was extracted and the complete
XML entry was downloaded from the NCBI protein
database. Information on sequence, position-specific
annotations, functional descriptions, and source organ-
ism was extracted from the entry and parsed by an
automated retrieval system into an in-house developed
relational database system [17]. For BLAST results
representing protein structures, monomers were
extracted from the PDB [18] and deposited as structure
entries.
Sequences generated from the annotated mutation
profiles deposited in the SHV mutation table [13] were
also incorporated into the SHVED. Except for 16
assigned SHVs which were “withdrawn” or “not yet
released”, 117 assigned SHV sequences were generated
and parsed into the SHVED using the available informa-
tion on amino acid exchanges and the reference
sequence SHV-1. On the webpage, the “source organ-
ism” of these sequences was set to “Clinical sample” and
t h ed a t as o u r c et o‘lc’ abbreviated from “Lahey Clinic”
where the SHV mutation table is hosted.
Identification and naming of SHV b-lactamase sequences
Each protein sequence in the SHVED was aligned with
SHV-1 using ClustalW [19] to identify its mutation pro-
file. This mutation profile is the set of amino acid
exchanges, deletions, and insertions occurring in a cer-
tain SHV, e.g. L35Q for the substitution of leucine at
position 35 by glutamine. Subsequently, the mutation
profile was matched against the mutation profiles listed
in the SHV mutation table to identify whether the
respective protein sequence is identical to an already
assigned SHV. If the mutation profiles were identical,
the protein was named accordingly (e.g. “SHV-3”).
Otherwise it was named “SHV-like” and its mutation
profile was stored. In the case of sequences longer than
SHV-1, only the region corresponding to SHV-1 was
examined to identify the mutation profile. Amino acid
insertions arising inside the protein sequence were
annotated, e.g. “-162.1D -162.2R” for the insertion of
two residues aspartic acid and arginine after the residue
at position 162. The amino acid deletion was annotated
with the corresponding residue and position, e.g. “G54-”
for the deletion of a glycine at position 54.
For sequences longer than SHV-1, the number of
additional residues was recorded, e.g. “C+5” for a
sequence 5 residues longer at its C terminus. Sequences
shorter than SHV-1 were considered as fragments of the
respective SHV sequences or the SHV-like sequences,
although they were probably named differently in the
entry of the source database. The number of missing
residues at the N- and C- terminus were annotated, e.g.
“N-21 C-3” for 21 and 3 residues missing at the N- and
C- terminus, respectively.
Multisequence alignment and feature annotation
The annotation information was enriched by performing
multisequence alignment using CLUSTALW [19]. Infor-
mation on secondary structure calculated using DSSP
[20] were also included in the SHVED. Individual resi-
dues in the sequence as well as in the alignments were
numbered according to the standard scheme suggested
by Ambler [15]
Reconciliation of data inconsistencies
A systematic comparison of entries of the NCBI protein
database and the SHV mutation table allows a reconci-
liation of NCBI protein database entries which have an
inconsistent annotation. In the SHVED, the wrong
name assignment is corrected if its mutation profile is
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with a new mutation profile is stored in the SHVED as
new SHV b-lactamase, even if it has been named by the
authors by a (wrong) SHV name in the NCBI protein
database. A link from the reconciled SHVED entry to
the original NCBI protein database entry allows the
author of the respective entry to correct an erroneous
entry.
Content
Data content of the SHVED
452 protein sequence entries from NCBI protein database
and 117 protein sequences from SHV mutation table
were collected and parsed into the SHVED, resulting in
200 distinct protein entries. 20 crystal structures of 2
SHV b-lactamases (SHV-1 and SHV-2) were stored in
the SHVED. 19 crystal structures were from SHV-1 with
one or two engineered mutations. Apart from the struc-
ture (PDB entry 3D4F) which is full-length sequence, all
crystal structures lack the 21 residues of the N-terminal
signal sequence. Two protein sequences (PDB entries
2A3U and 2A49) possess 5 and 4 additional residues,
respectively, at their C-terminus (Table 1).
Of the 200 proteins, 35 SHV sequences were derived
from SHV mutation table, but not from the NCBI pro-
tein database, 82 protein sequences were exclusively
found in the NCBI protein database, and 83 protein
sequences were accessible in both source databases. In
82 protein sequences found only in the NCBI protein
database, there are 41 sequences which originate from
microbial sources and harbor a new mutation profile. 22
are full-length sequences (table 2) and 19 are fragments
(table 3).
Analysis of amino acid substitutions and substitution
positions
In addition to the amino acid substitutions described
in the SHV mutation table [13], 27 new substitution
Table 1 PDB code of crystal structure entries in SHVED
and their sequence annotations
Protein PDB ID Description
SHV-1 3D4FA structure of SHV-1
1ONGA structure (N-21) of SHV-1
1Q2PA
1SHVA
1VM1A
2G2UA
2H5SA
2ZD8A
3C4OA
3C4PA
1TDGA structure (N-21) of SHV-1 with the artificial S130G
mutation and tazobactam [S130G]
1TDLA
2A3UA structure (N-21 C+5) of SHV-1 with the artificial
E166A mutation and sulbactam [E166A]
2G2WA structure (N-21) of SHV-1 with the artificial D104K
mutation [D104K]
2A49A structure (N-21 C+4) of SHV-1 with the artificial
E166A mutation and clavulanic acid [E166A]
1RCJA structure (N-21) of SHV-1 with the artificial E166A
mutation [E166A]
2H0TA structure (N-21) of SHV-1 with artificial M69V,
E166A mutations [M69V E166A]
2H0YA
2H10A
SHV-2 1N9BA structure (N-21) of SHV-2 [G238S]
Table 2 New mutation profiles of full length sequences
originating from microorganisms
GI Source Organism Description *
74058441 Klebsiella pneumoniae SHV-like [A52T]
224223446 Klebsiella pneumoniae SHV-like [E166K]
154269503 Klebsiella pneumoniae SHV-like [K256R]
160948441 Klebsiella pneumoniae SHV-like [N253H]
218091981 Klebsiella pneumoniae SHV-like [S271I]
161367444 Klebsiella pneumoniae SHV-like [R202S]
218091983 Klebsiella pneumoniae SHV-like [D104G]
218091988 Klebsiella pneumoniae SHV-like [Y7F G238S]
262044380 Klebsiella pneumoniae SHV-like [P252L]
41584432 Escherichia coli SHV-like [T235N G238S E240K]
218684515 Klebsiella pneumoniae SHV-like [H289L]
51150101 Klebsiella pneumoniae SHV-like [R6L G238S E240K]
51105097 Escherichia coli
30230495 Acinetobacter baumannii SHV-like [L35Q R191H G238S
E240K]
33943602 Acinetobacter baumannii SHV-like [S14Y L35Q G238S
E240K]
52630976 Klebsiella pneumoniae SHV-like [L35Q G238S E240K
I260V]
41584438 Escherichia coli SHV-like [L35Q T235N G238S
E240K]
257359515 Klebsiella pneumoniae SHV-like [T18A A22V L35Q
M129V]
41584428 Escherichia coli SHV-like [L35Q T235N G238S
E240K S271N]
224979335 Salmonella enterica SHV-like [L35Q K94E G238S
E240K]
83596180 Acinetobacter baumannii SHV-like [L35Q G238S E240K
N254D]
84380855 Klebsiella pneumoniae SHV-like [Y7F L35Q G238S
E240R]
15718691 Klebsiella pneumoniae SHV-like [H96T Y97H -162.1D
-162.2R -162.3W -162.4E
-162.5T]
*SHV-like: SHV variant with a mutation profile that is not in the SHV mutation
table. The mutatation profile is given in square brackets.
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sources have been identified. 11 new substitution posi-
tions found in full length sequences (table S1, Addi-
tional file 1) and 18 new substitution positions were
found in fragments (table S2, Additional file 1), in which
2 new substitution positions could be found both in full
length sequences and in fragments (positions 6 and
289). These new substitution positions spread over the
complete protein sequence, including the signal peptide
and the C-terminus. Most of the substitutions found in
full length sequences are located at the protein surface
and are distant from the active site, except for T235 and
I260 (figure 1). Of the 18 new substitution positions
found in fragments, 9 positions are at the C terminus, 4
positions on the protein surface, 3 positions in the pro-
tein core, and 2 in the signal peptide (figure 2). Not
only the substitution at new positions, but also new
amino acid exchanges at already known positions were
found. As an example, the protein sequence with GI
259038268 harbors an lysine at the position 252 instead
of a proline. In the SHV mutation table, only the substi-
tution P252G is described.
Data inconsistencies
There are 27 distinct protein entries derived from the
NCBI protein database having inconsistent annotations
(table 4). In all cases, the annotated SHV name is
inconsistent with its mutation profile. For example,
the protein sequence with GI 40950644 has three
mutations (L35Q, G238S, and E240K), therefore, it
should be named “SHV-12” according to the SHV
mutation table, but it is actually annotated as “beta-
lactamase SHV-5” in the NCBI protein database. In 12
cases, the protein sequence is a fragment and therefore
there is not enough information to rename it in the
SHVED.
Utility
A multisequence alignment of all 200 protein entries
was generated using CLUSTALW. For protein struc-
tures, all sequence entries were included and displayed
with aligned secondary structure information. Proteins
were labeled by the GIs and linked to the NCBI protein
database. Annotation of individual residues is visualized
by color-coding in the alignment and upon moving the
Table 3 Fragments with new mutation profiles
GI Microbial source Description *
41584430 Escherichia coli fragment (C-1) of SHV-like [L35Q T235N G238S E240K]
40950646 Escherichia coli fragment (C-2) of SHV-like [L35Q D233E G238S E240K]
164665324 Escherichia coli fragment (C-3) of SHV-like [G238S E240X]
90403947 Klebsiella
pneumoniae
fragment (C-4) of SHV-like [L35Q G238S E240K E288F]
94502905 Klebsiella
pneumoniae
fragment (N-1 C-3) of SHV-like [R6E Y7G I8D R9S L35Q H289L]
90403949 Escherichia coli fragment (N-2 C-7) of SHV-like [Y7W I8V R9I L10F C11P L35Q G238S E240K]
90403945 Klebsiella
pneumoniae
fragment (N-9 C-1) of SHV-like [L35Q G238S E240K E288N H289L W290G Q291T]
78333 Escherichia coli fragment (N-21) of SHV-like [A140T T141A]
90403951 Klebsiella
pneumoniae
fragment (N-10 C+1) of SHV-like [L35Q G238S E240K A284R A285P L286Y I287K E288N H289L W290E Q291P
R292K]
157838542 Escherichia coli fragment (N-19 C-2) of SHV-like [R43S G238S E240K]
46309198 Klebsiella
pneumoniae
fragment (N-12 C-11) of SHV-like [P252L]
159138973 Klebsiella
pneumoniae
fragment (N-23 C-5) of SHV-like [L35Q E168A G251S]
159138975 Klebsiella
pneumoniae
fragment (N-24 C-5) of SHV-like [L35Q E168A G251S]
56463227 Escherichia coli fragment (N-25 C-13) of SHV-like [E89Q G238S E240K]
56463237 Escherichia coli fragment (N-25 C-13) of SHV-like [V80M G238S E240K]
56463225 Escherichia coli fragment (N-25 C-13) of SHV-like [R43S G238S E240K]
56463229 Escherichia coli fragment (N-25 C-13) of SHV-like [R43S E89Q G238S E240K]
56463239 Escherichia coli fragment (N-25 C-13) of SHV-like [V44G V80M E89Q G238S E240K G251V M272R]
56463235 Escherichia coli fragment (N-25 C-13) of SHV-like [R43S D213A T235P G238S E240K E258D V261L]
* SHV-like: SHV variant with a mutation profile that is not in the SHV mutation table.
N-x C-y: sequence lacks × amino acids at the N terminus and y amino acids at the C terminus. The mutatation profile is given in square brackets.
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Page 4 of 8Figure 1 The structure of SHV-1 b-lactamases (PDB entry 1SHV) with new substitution positions found in full length sequences. Amino
acid side chains are shown in stick representation: substitutions occurring at novel positions (green), novel amino acid substitution at known
position (red), active site residues (yellow).
Figure 2 The structure of SHV-1 b-lactamases (PDB entry 1SHV) with new substitution positions found in fragments. Amino acid side
chains are shown in stick representation: substitutions occurring at novel positions (green), novel amino acid substitution at known position
(red), active site residues (yellow).
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sible at http://www.LacED.uni-stuttgart.de/classA/
SHVED by a JavaScript-enabled WWW browser. Protein
tables provide information on the protein name, muta-
tion, number of residues missing at the N- and C-term-
inal (in case of fragments), and on the source organism.
As an alternative to the multisequence alignment, the
SHV variants are visualized as mutations relative to the
sequence of SHV-1. Substitution positions are colored
and annotated by the exchanged amino acids.
Discussion
Data content of the SHVED
By systematic analysis of protein sequences in the
SHVED, 41 protein sequences with a new mutation pro-
file were identified. 22 of them are full length sequences
originating from microbial sources and therefore are
candidates for a new SHV number assignment. The new
mutations occurred either at new position on the
sequence or they were new amino acid exchange at
already described positions.
Table 4 Inconsistencies between information from NCBI protein database and SHV mutation table
GI Name and mutation profile according to Inconsistency
NCBI protein database SHV mutation table*
262044380 SHV-5 [G238S E240K] SHV-like [P252L] different mutation profile
41584432 SHV-5 [G238S E240K] SHV-like [T235N G238S E240K]
51105097 SHV-5 [G238S E240K] SHV-like [R6L G238S E240K]
40950644 SHV-5 [G238S E240K] SHV-12 [L35Q G238S E240K]
41584438 SHV-5 [G238S E240K] SHV-like [L35Q T235N G238S E240K]
41584428 SHV-5 [G238S E240K] SHV-like [L35Q T235N G238S E240K S271N]
41584434 SHV-5 [G238S E240K] fragment (C-1) of SHV-12 [L35Q G238S E240K] a fragment with different
mutation profile
41584430 SHV-5 [G238S E240K] fragment (C-1) of SHV-like [L35Q T235N G238S E240K]
40950646 SHV-5 [G238S E240K] fragment (C-2) of SHV-like [L35Q D233E G238S E240K]
157838542 SHV-7 [I8F R43S G238S E240K] fragment (N-19 C-2) of SHV-like [R43S G238S E240K]
77702548 SHV-11 [L35Q] SHV-1 (no mutation) different mutation profile
90403947 SHV-12 [L35Q G238S E240K] fragment (C-4) of SHV-like [L35Q G238S E240K E288F] a fragment with different
mutation profile
90403949 SHV-12 [L35Q G238S E240K] fragment (N-2 C-7) of SHV-like [Y7W I8V R9I L10F C11P L35Q G238S
E240K]
90403945 SHV-12 [L35Q G238S E240K] fragment (N-9 C-1) of SHV-like [L35Q G238S E240K E288N H289L W290G
Q291T]
90403951 SHV-12 [L35Q G238S E240K] fragment (N-10 C+1) of SHV-like [L35Q G238S E240K A284R A285P L286Y
I287K E288N H289L W290E Q291P R292K]
15718691 SHV-16 [-162.1D -162.2R
-162.3W -162.4E -162.5T]
SHV like [H96T Y97H -162.1D -162.2R -162.3W -162.4E -162.5T] different mutation profile
255045865 SHV-28 [Y7F] fragment (N-6 C-20) of SHV-1 a fragment with different
mutation profile
30230495 SHV-48 [V119I] SHV-like [L35Q R191H G238S E240K] different mutation profile
33943602 SHV-56 [L35Q K234R] SHV-like [S14Y L35Q G238S E240K]
83596180 SHV-71 [H112Y A146V] SHV-like [L35Q G238S E240K N254D]
84380855 SHV-86 [L35Q G238S E240R] SHV-like [Y7F L35Q G238S E240R]
159138975 SHV-102 [G238A] fragment (N-24 C-5) of SHV-like [L35Q E168A G251S] a fragment with different
mutation profile
159138973 SHV-102 [G238A] fragment (N-23 C-5) of SHV-like [L35Q E168A G251S]
154269503 SHV-103 [L250R] SHV-like [K256R] different mutation profile
161367444 SHV-104 [M5L R202S] SHV-like [R202S]
257359515 SHV-121 [I8A A22V L35Q
M129V]
SHV-like [T18A A22V L35Q M129V]
256862196 SHV-123 [L35Q G238S E240K
P252G N254I]
fragment (C-15) of SHV-like [L35Q G238S E240K P252G N255I] a fragment with different
mutation profile
* SHV-like: SHV variant with a mutation profile that is not in the SHV mutation table.
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acid substitutions
Except for one new mutation profile originating from a
synthetic construct (GI 151861), all new mutation pro-
files originated from microbial sources. As a plasmid-
bound gene, the SHV b-lactamase encoding blaSHV
genes are easily transferred among the members of
Gram-negative bacteria, especially Enterobacteriaceae
because of their close genetic relationship [6]. Thus,
most of the newly detected SHV b-lactamases are from
Enterobacteriaceae such as Klebsiella pneumoniae (14
SHVs), Escherichia coli (15 SHVs), Enterobacter cloacae
(1 SHV), from both K.pneumoniae and E.coli (1 SHV),
and from both K.pneumoniae and E.cloacae (1 SHV).
Additionally, 3 new SHV variants were found in Acine-
tobacter baumannii and 1 new SHV variant was found
in Salmonella enterica. Although 19 fragments harbor a
new mutation profile, they can not be assigned to a new
SHV number because of missing sequence information.
However, the information about the substitution at new
positions found in these fragments could be used in the
future to predict the occurrence of new SHV variants.
Data inconsistencies and reconciliation
In all 27 cases of inconsistency, the annotated name dif-
fered from the actual mutation profile. However, the rea-
sons of the inconsistency varied. In the case of the
protein sequence with GI 154269503, the lysine at posi-
tion 256 is substituted by an arginine, while it is reported
that the lysine is exchanged by an arginine at position
250 (K250R) [21]. In the SHV mutation table, it is listed
as SHV-103 and characterized by the substitution of a
leucine at position 250 by an arginine (L250R). A muta-
tion at position 256 is not yet recorded in the SHV muta-
tion table, and the mutation at position 250 can only be
seen in the SHV-103. Probably, the difference in amino
acid numbering by the author of GI 154269503 and by
the curators of the SHV mutation table at Lahey Clinic
caused the inconsistence. In the case of the protein
sequence with GI 161367444, the inconsistency might
derive from the primer used. In the sequence, only
one mutation R202S was found, while it is annotated as
SHV-104 which has two mutations (M5L and R202S)
according to the SHV mutation table. It is noted in the
N C B Ie n t r yt h a tt h ef o r w a r dp r i m e r“ATGCGTTA-
TATTCGCCTGTGTATT” was used to amplify the tar-
get DNA, which results a methionine at position 5.
Therefore, the deduced amino acid substitution M5L (if
it actually occurred) could not be present in the depos-
ited amino acid sequence, and the deposited amino acid
sequence should not be annotated as SHV-104 because
it does not harbor the mutation profile ‘M5L R202S’.I n
the case of the protein sequence with GI 15718691, the
duplication of a pentapeptide 163DRWET167 was
r e p o r t e d[ 2 2 ]a n da s s i g n e da sS H V - 1 6 .B u ti na d d i t i o n ,
two mutations H96T and Y97H are present in the amino
acid sequence. Therefore, it is not clear whether the
actual SHV-16 harbors only the pentapeptide duplication
or additionally the mutations H96T and Y97H. In other
cases of inconsistency, the amino acid sequences were
submitted to the NCBI protein database without corre-
sponding publication and showed inconsistencies in their
annotation. One example is the protein sequence with
GI 30230495. It is annotated as SHV-48 which should
harbor mutation V119I according to the SHV mutation
table, while actually four mutations (L35Q, R191H,
G238S, and E240K) were found in the deposited amino
acid sequence. In the SHV mutation table, an inconsis-
tency in residue numbering (position 253 and 255) was
revealed and communicated to the curator for correction.
Conclusion
The SHV Lactamase Engineering Database (SHVED) was
established to identify new SHV b-lactamases and to
identify inconsistencies in public databases. Based on our
analysis, 22 candidates for assignment of new SHV
names were identified. 27 proteins entries with inconsis-
tencies were found and reconciled. Also, three assigned
mutation profiles were identified to be in doubt: SHV-16,
SHV-103, and SHV-104. The SHVED thus supports the
scientific community to name new SHV b-lactamases
and to reconcile existing annotation of SHV b-lactamases
sequences.
Availability and requirements
The SHVED is accessible at http://www.LacED.uni-stutt-
gart.de/classA/SHVED/ by a JavaScript-enabled WWW
browser.
Additional material
Additional file 1: Additional_file_1.pdf contains table S1 and table
S2 mentioned in the text. They list new mutation profiles of sequences
derived from microbial organisms.
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GI: GenInfo Identifier; SHVED: SHV Engineering Database.
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